Protein kinase C-zeta mediates retinal degeneration in response to TNF

Hong Liang1, Christophe Baudouin, Francine Behar-Cohen

  • 1INSERM, U598, Physiopathology of ocular diseases: therapeutic innovations, Department of Ophthalmology, Quinze-Vingts National Ophthalmology Hospital, AP-HP, Paris Ouest School of Medicine, Paris, France.

Insights

Tumor necrosis factor-alpha (TNF) did not cause retinal cell death alone. However, inhibiting protein kinase C zeta (PKCzeta) with TNF induced apoptosis in retinal ganglion cells, revealing a protective role for PKCzeta.

Area of Science:

  • Ophthalmology
  • Neuroscience
  • Cell Biology

Background:

  • Glaucoma is associated with retinal ganglion cell (RGC) degeneration, potentially mediated by tumor necrosis factor-alpha (TNF).
  • Atypical protein kinase C zeta (PKCzeta) plays a role in cellular protection against stress.

Purpose of the Study:

  • To investigate the proapoptotic effects of intravitreal TNF injections, with or without a specific PKCzeta inhibitor, on rat retinas.
  • To elucidate the interplay between TNF and PKCzeta signaling in retinal cell survival and apoptosis.

Main Methods:

  • Intravitreal injections of TNF and/or a PKCzeta-specific inhibitor in rat eyes.
  • Immunohistochemistry and Western blotting to analyze PKCzeta and NF-kappaB expression.
  • TUNEL assay to quantify apoptosis in retinal tissues.

Main Results:

  • TNF alone did not induce retinal apoptosis but increased PKCzeta expression in bipolar cells.
  • Coinjection of TNF with the PKCzeta inhibitor led to apoptosis in the inner nuclear and ganglion cell layers.
  • PKCzeta inhibition unmasked retinal cells to TNF-induced cytotoxicity.

Conclusions:

  • The study demonstrates a link between TNF's proapoptotic effects and the antiapoptotic PKCzeta signaling pathway.
  • PKCzeta acts as a protective factor against TNF-induced retinal cell death.
  • Targeting PKCzeta may influence therapeutic strategies for glaucoma and related optic neuropathies.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...